US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ACLARION, INC

4.78

-3.3900-41.49%

Post-market: 4.890.1100+2.30%19:59 EST

Volume:2.44M

Turnover:13.18M

Market Cap:3.21M

PE:0.00

High:5.96

Open:5.88

Low:4.67

Close:8.17

52wk High:1,241.88

52wk Low:4.32

Shares:671.40K

Float Shares:671.30K

Volume Ratio:0.28

T/O Rate:362.86%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1,597.9500

EPS(LYR):-8.8206

ROE:-97.72%

ROA:-52.37%

PB:0.26

PE(LYR):-0.54

Loading ...

Overview Company News Filings

Aclarion Inc trading halted, volatility trading pause

Aclarion's AI Back Pain Tech Sees 114% Surge In Demand, Stock Soars

Benzinga_recent_news

Aclarion Launches CLARITY Trial to Advance Nociscan for Chronic Low Back Pain

Aclarion Inc - Aims to Enroll 25% in Clarity Trial by Q2 2026

THOMSON REUTERS

Aclarion Provides 2025 Update and 2026 Corporate Outlook

THOMSON REUTERS

Aclarion Inc - Cash Resources Sufficient to Fund Operations Into 2027

THOMSON REUTERS

BRIEF-Aclarion Announces First Patient Enrollments At Two Additional Clarity Trial Sites

Aclarion Inc - First Interim Data Readout Expected in 3Q 2026

THOMSON REUTERS

Aclarion Inc - Acclarion Targets Full Enrollmentof 300 Patients by Mid-2027

THOMSON REUTERS

Aclarion Announces First Patient Enrollments at Two Additional Clarity Trial Sites and Provides Guidance on Expected Availability of Initial Data

THOMSON REUTERS

Aclarion Launches CLARITY Trial with First Patients Enrolled at Leading Spine Centers

Aclarion Nociscan Study Published in Leading Spine Surgery Journal

Press Release: Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S.

Aclarion CEO Brent Ness Reports Acquisition of Common Shares

Aclarion Is Maintained at Buy by Ascendiant Capital

Aclarion Q3 EPS $(2.93) Misses $(2.62) Estimate, Sales $18.942K Miss $40.000K Estimate

Press Release: Aclarion Appoints Dan Isherwood as UK Commercial Director to Drive Adoption and Market Expansion

BRIEF-Aclarion Inc - Clarity Trial On Schedule, Early Readouts Expected Q2 2026

Aclarion Inc. Announces $2.5 Million Registered Direct Offering of 64,000 Shares and Pre-Funded Warrants for 236,000 Shares

Aclarion Inc to Present at LD Micro Main Event XIX

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ACON/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACON","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACON\",,,,,undefined,":{"symbol":"ACON","market":"US","secType":"STK","nameCN":"ACLARION, INC","latestPrice":4.78,"timestamp":1767992400000,"preClose":8.17,"halted":0,"volume":2435888,"hourTrading":{"tag":"盘后","latestPrice":4.89,"preClose":4.78,"latestTime":"19:59 EST","volume":54975,"amount":265464.3337,"timestamp":1768006746364},"delay":0,"floatShares":671300,"shares":671400,"eps":-1597.95,"marketStatus":"Market Closed","change":-3.39,"latestTime":"01-09 16:00:00 EST","open":5.88,"high":5.96,"low":4.67,"amount":13178560.873296,"amplitude":0.157895,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1597.95,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1768208400000},"marketStatusCode":7,"adr":0,"listingDate":1650600000000,"exchange":"NASDAQ","adjPreClose":8.17,"preHourTrading":{"tag":"盘前","latestPrice":5.94,"preClose":8.17,"latestTime":"09:29 EST","volume":238225,"amount":1476851.49326,"timestamp":1767968994162},"postHourTrading":{"tag":"盘后","latestPrice":4.89,"preClose":4.78,"latestTime":"19:59 EST","volume":54975,"amount":265464.3337,"timestamp":1768006746364},"volumeRatio":0.27935222384654085},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACON\",,,,,undefined,":{"symbol":"ACON","floatShares":671300,"roa":"-52.37%","roe":"-97.72%","lyrEps":-8.820588,"volumeRatio":0.27935222384654085,"shares":671400,"dividePrice":0,"high":5.96,"amplitude":0.157895,"preClose":8.17,"low":4.67,"week52Low":4.32,"pbRate":"0.26","psRate":"47.56","week52High":1241.8785,"institutionHeld":0,"latestPrice":4.78,"eps":-1597.95,"divideRate":0,"volume":2435888,"delay":0,"ttmEps":-1597.95,"open":5.88,"prevYearClose":4.6,"prevWeekClose":4.98,"prevMonthClose":4.6,"prevQuarterClose":4.6,"fiveDayClose":4.98,"twentyDayClose":6.76,"sixtyDayClose":8.95},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACON\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-12","symbol":"ACON","fiscalQuarterEnding":"2025/09","expectedEps":-2.64,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-2.93},{"market":"US","date":"2025-08-14","symbol":"ACON","fiscalQuarterEnding":"2025/06","expectedEps":-2.26,"name":null,"time":"","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"","actualEps":-2.75},{"market":"US","date":"2025-03-28","symbol":"ACON","defaultRemindTime":1743168600000,"type":"split","dateTimestamp":1743134400000,"forFactor":27,"toFactor":1,"ratio":27},{"market":"US","date":"2025-01-30","symbol":"ACON","defaultRemindTime":1738247400000,"type":"split","dateTimestamp":1738213200000,"forFactor":335,"toFactor":1,"ratio":335},{"market":"US","date":"2024-01-04","symbol":"ACON","defaultRemindTime":1704378600000,"type":"split","dateTimestamp":1704344400000,"forFactor":16,"toFactor":1,"ratio":16}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACON\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACON\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1734152400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ACON\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ACON","date":"2026-01-09","current":-0.002991,"percent":0.321001,"low":-6.309952,"twenty":-0.87971,"median":-0.63734,"eighty":-0.420734,"high":-0.08249,"avg":-0.744938,"sd":0.554291,"marketCap":5485101},"quantilePoints":[{"date":"2022-04-22","current":-4.297979,"twenty":-6.309952,"median":-6.309952,"eighty":-5.102768,"marketCap":21276242},{"date":"2022-04-29","current":-3.270888,"twenty":-5.505163,"median":-3.950348,"eighty":-3.536446,"marketCap":16191846},{"date":"2022-05-06","current":-3.17608,"twenty":-4.190529,"median":-3.697526,"eighty":-3.214003,"marketCap":15722517},{"date":"2022-05-13","current":-2.307003,"twenty":-3.966149,"median":-3.310391,"eighty":-2.736802,"marketCap":11420336},{"date":"2022-05-20","current":-2.812648,"twenty":-3.808135,"median":-3.033868,"eighty":-2.351247,"marketCap":13923423},{"date":"2022-05-27","current":-1.975174,"twenty":-3.707007,"median":-2.788946,"eighty":-2.259599,"marketCap":9777685},{"date":"2022-06-03","current":-1.695648,"twenty":-3.643833,"median":-2.741542,"eighty":-2.180592,"marketCap":8393947},{"date":"2022-06-10","current":-1.464207,"twenty":-3.413227,"median":-2.38601,"eighty":-1.978334,"marketCap":7860622},{"date":"2022-06-17","current":-1.282092,"twenty":-3.334094,"median":-2.322805,"eighty":-1.541424,"marketCap":6882933},{"date":"2022-06-24","current":-1.31123,"twenty":-3.270888,"median":-2.212195,"eighty":-1.511266,"marketCap":7039363},{"date":"2022-07-01","current":-1.340369,"twenty":-3.17608,"median":-2.180592,"eighty":-1.456485,"marketCap":7195793},{"date":"2022-07-08","current":-1.235616,"twenty":-3.06231,"median":-2.014678,"eighty":-1.307005,"marketCap":6633426},{"date":"2022-07-15","current":-1.251496,"twenty":-2.907457,"median":-1.951472,"eighty":-1.290076,"marketCap":6718681},{"date":"2022-07-22","current":-1.223815,"twenty":-2.825289,"median":-1.588046,"eighty":-1.282063,"marketCap":6570072},{"date":"2022-07-29","current":-1.413215,"twenty":-2.774725,"median":-1.522484,"eighty":-1.279148,"marketCap":7586869},{"date":"2022-08-05","current":-1.573476,"twenty":-2.765244,"median":-1.529769,"eighty":-1.282063,"marketCap":8447236},{"date":"2022-08-12","current":-1.314146,"twenty":-2.727321,"median":-1.529769,"eighty":-1.282092,"marketCap":7055014},{"date":"2022-08-19","current":-0.895775,"twenty":-2.61747,"median":-1.511266,"eighty":-1.259218,"marketCap":7712795},{"date":"2022-08-26","current":-0.962906,"twenty":-2.427283,"median":-1.478776,"eighty":-1.236665,"marketCap":8290805},{"date":"2022-09-02","current":-1.071914,"twenty":-2.373369,"median":-1.456777,"eighty":-1.223815,"marketCap":9229387},{"date":"2022-09-09","current":-1.117335,"twenty":-2.351247,"median":-1.413215,"eighty":-1.193074,"marketCap":9620463},{"date":"2022-09-16","current":-1.01741,"twenty":-2.319644,"median":-1.361349,"eighty":-1.133686,"marketCap":8760096},{"date":"2022-09-23","current":-0.822831,"twenty":-2.259599,"median":-1.330899,"eighty":-1.110068,"marketCap":7084728},{"date":"2022-09-30","current":-0.706737,"twenty":-2.209035,"median":-1.312688,"eighty":-1.044662,"marketCap":6085138},{"date":"2022-10-07","current":-0.799485,"twenty":-2.186913,"median":-1.30176,"eighty":-0.997425,"marketCap":6883715},{"date":"2022-10-14","current":-0.828644,"twenty":-2.180592,"median":-1.28821,"eighty":-0.953422,"marketCap":7134785},{"date":"2022-10-21","current":-0.749704,"twenty":-2.142669,"median":-1.282092,"eighty":-0.913852,"marketCap":6455096},{"date":"2022-10-28","current":-0.917486,"twenty":-2.055762,"median":-1.264171,"eighty":-0.897901,"marketCap":7899730},{"date":"2022-11-04","current":-0.862982,"twenty":-2.000456,"median":-1.251496,"eighty":-0.897901,"marketCap":7430439},{"date":"2022-11-11","current":-0.899318,"twenty":-1.981494,"median":-1.236271,"eighty":-0.890234,"marketCap":7743299},{"date":"2022-11-18","current":-0.879796,"twenty":-1.946732,"median":-1.226437,"eighty":-0.888962,"marketCap":6414424},{"date":"2022-11-25","current":-0.879689,"twenty":-1.914262,"median":-1.223815,"eighty":-0.8827,"marketCap":6413642},{"date":"2022-12-02","current":-0.944056,"twenty":-1.814659,"median":-1.206769,"eighty":-0.879689,"marketCap":6882933},{"date":"2022-12-09","current":-0.767046,"twenty":-1.687573,"median":-1.144587,"eighty":-0.865344,"marketCap":5592383},{"date":"2022-12-16","current":-0.654295,"twenty":-1.657978,"median":-1.12869,"eighty":-0.854817,"marketCap":4770341},{"date":"2022-12-23","current":-0.51494,"twenty":-1.625925,"median":-1.117335,"eighty":-0.82429,"marketCap":3754327},{"date":"2022-12-30","current":-0.622219,"twenty":-1.611356,"median":-1.071914,"eighty":-0.806261,"marketCap":4536478},{"date":"2023-01-06","current":-0.622219,"twenty":-1.588046,"median":-1.059703,"eighty":-0.779318,"marketCap":4536478},{"date":"2023-01-13","current":-0.590035,"twenty":-1.588046,"median":-1.044662,"eighty":-0.761682,"marketCap":4301833},{"date":"2023-01-20","current":-0.67264,"twenty":-1.57639,"median":-1.023645,"eighty":-0.750431,"marketCap":4904089},{"date":"2023-01-27","current":-0.745697,"twenty":-1.53851,"median":-0.981074,"eighty":-0.745608,"marketCap":5436735},{"date":"2023-02-03","current":-0.643675,"twenty":-1.529769,"median":-0.97199,"eighty":-0.73993,"marketCap":4692909},{"date":"2023-02-10","current":-0.839245,"twenty":-1.518113,"median":-0.962906,"eighty":-0.744236,"marketCap":6118771},{"date":"2023-02-17","current":-0.794938,"twenty":-1.512053,"median":-0.95121,"eighty":-0.745608,"marketCap":5795742},{"date":"2023-02-24","current":-0.75664,"twenty":-1.496143,"median":-0.937426,"eighty":-0.748101,"marketCap":5516514},{"date":"2023-03-03","current":-0.739581,"twenty":-1.486061,"median":-0.92657,"eighty":-0.745519,"marketCap":5624913},{"date":"2023-03-10","current":-0.683247,"twenty":-1.47732,"median":-0.91468,"eighty":-0.739343,"marketCap":5196461},{"date":"2023-03-17","current":-0.826925,"twenty":-1.467121,"median":-0.908402,"eighty":-0.727267,"marketCap":6289212},{"date":"2023-03-24","current":-0.857935,"twenty":-1.459749,"median":-0.901252,"eighty":-0.729756,"marketCap":6525057},{"date":"2023-03-31","current":-0.671876,"twenty":-1.456602,"median":-0.899318,"eighty":-0.727267,"marketCap":5109984},{"date":"2023-04-06","current":-0.730795,"twenty":-1.439177,"median":-0.895775,"eighty":-0.723683,"marketCap":5558091},{"date":"2023-04-14","current":-0.820723,"twenty":-1.404415,"median":-0.890192,"eighty":-0.723683,"marketCap":6242042},{"date":"2023-04-21","current":-0.814418,"twenty":-1.38766,"median":-0.887055,"eighty":-0.725941,"marketCap":6194087},{"date":"2023-04-28","current":-0.78072,"twenty":-1.365544,"median":-0.883425,"eighty":-0.727085,"marketCap":5937802},{"date":"2023-05-05","current":-0.785579,"twenty":-1.340369,"median":-0.879689,"eighty":-0.723931,"marketCap":5974751},{"date":"2023-05-12","current":-0.775242,"twenty":-1.338475,"median":-0.868887,"eighty":-0.72568,"marketCap":5896136},{"date":"2023-05-19","current":-0.712706,"twenty":-1.3302,"median":-0.862982,"eighty":-0.723931,"marketCap":5420514},{"date":"2023-05-26","current":-0.651203,"twenty":-1.327402,"median":-0.859738,"eighty":-0.713223,"marketCap":4952754},{"date":"2023-06-02","current":-1.064666,"twenty":-1.323944,"median":-0.862112,"eighty":-0.713223,"marketCap":8097360},{"date":"2023-06-09","current":-1.32308,"twenty":-1.32308,"median":-0.866386,"eighty":-0.713305,"marketCap":10062739},{"date":"2023-06-16","current":-1.26106,"twenty":-1.323944,"median":-0.87447,"eighty":-0.720685,"marketCap":9591048},{"date":"2023-06-23","current":-1.066415,"twenty":-1.32308,"median":-0.879743,"eighty":-0.723145,"marketCap":8110665},{"date":"2023-06-30","current":-0.800527,"twenty":-1.319506,"median":-0.879743,"eighty":-0.724303,"marketCap":5658603},{"date":"2023-07-07","current":-0.818298,"twenty":-1.313563,"median":-0.87447,"eighty":-0.72568,"marketCap":5986638},{"date":"2023-07-14","current":-0.728621,"twenty":-1.31123,"median":-0.866386,"eighty":-0.726904,"marketCap":5330568},{"date":"2023-07-21","current":-0.7275,"twenty":-1.309465,"median":-0.862112,"eighty":-0.726878,"marketCap":5322367},{"date":"2023-07-28","current":-0.639057,"twenty":-1.302278,"median":-0.858233,"eighty":-0.718793,"marketCap":4675318},{"date":"2023-08-04","current":-0.672574,"twenty":-1.30176,"median":-0.856195,"eighty":-0.713223,"marketCap":4920525},{"date":"2023-08-11","current":-0.616526,"twenty":-1.29207,"median":-0.853332,"eighty":-0.708054,"marketCap":4510481},{"date":"2023-08-18","current":-0.531445,"twenty":-1.290105,"median":-0.847505,"eighty":-0.696993,"marketCap":3888034},{"date":"2023-08-25","current":-0.51564,"twenty":-1.289959,"median":-0.83885,"eighty":-0.69255,"marketCap":3772402},{"date":"2023-09-01","current":-0.800367,"twenty":-1.286462,"median":-0.826925,"eighty":-0.69255,"marketCap":4182446},{"date":"2023-09-08","current":-0.721272,"twenty":-1.282966,"median":-0.826718,"eighty":-0.69255,"marketCap":3769122},{"date":"2023-09-15","current":-0.674819,"twenty":-1.282092,"median":-0.82444,"eighty":-0.682068,"marketCap":3526376},{"date":"2023-09-22","current":-0.627896,"twenty":-1.282063,"median":-0.821777,"eighty":-0.681634,"marketCap":3281170},{"date":"2023-09-28","current":-0.535304,"twenty":-1.281946,"median":-0.819929,"eighty":-0.674819,"marketCap":2797318},{"date":"2023-10-06","current":-0.670111,"twenty":-1.273553,"median":-0.818656,"eighty":-0.672529,"marketCap":3501773},{"date":"2023-10-13","current":-0.792392,"twenty":-1.263819,"median":-0.816152,"eighty":-0.671876,"marketCap":4140769},{"date":"2023-10-20","current":-0.896028,"twenty":-1.260654,"median":-0.818298,"eighty":-0.671876,"marketCap":4682337},{"date":"2023-10-27","current":-0.581182,"twenty":-1.260384,"median":-0.818298,"eighty":-0.671876,"marketCap":3037058},{"date":"2023-11-03","current":-0.485106,"twenty":-1.254556,"median":-0.815119,"eighty":-0.668228,"marketCap":2534997},{"date":"2023-11-10","current":-0.551256,"twenty":-1.251496,"median":-0.805207,"eighty":-0.661476,"marketCap":2880678},{"date":"2023-11-17","current":-0.670398,"twenty":-1.246397,"median":-0.804218,"eighty":-0.655759,"marketCap":3077553},{"date":"2023-11-24","current":-0.517164,"twenty":-1.238821,"median":-0.801627,"eighty":-0.654768,"marketCap":2374112},{"date":"2023-12-01","current":-0.517164,"twenty":-1.235878,"median":-0.800527,"eighty":-0.654252,"marketCap":2374112},{"date":"2023-12-08","current":-0.440547,"twenty":-1.235465,"median":-0.799797,"eighty":-0.643626,"marketCap":2022392},{"date":"2023-12-15","current":-0.421393,"twenty":-1.228235,"median":-0.795879,"eighty":-0.638647,"marketCap":1934462},{"date":"2023-12-22","current":-0.505671,"twenty":-1.224339,"median":-0.793501,"eighty":-0.629719,"marketCap":2321354},{"date":"2023-12-29","current":-0.421584,"twenty":-1.223815,"median":-0.792292,"eighty":-0.628302,"marketCap":1935341},{"date":"2024-01-05","current":-0.369916,"twenty":-1.223815,"median":-0.790397,"eighty":-0.627896,"marketCap":1698149},{"date":"2024-01-12","current":-0.640434,"twenty":-1.223815,"median":-0.787439,"eighty":-0.627896,"marketCap":2940000},{"date":"2024-01-19","current":-0.569071,"twenty":-1.217405,"median":-0.785579,"eighty":-0.627171,"marketCap":2612400},{"date":"2024-01-26","current":-0.34126,"twenty":-1.201349,"median":-0.778779,"eighty":-0.619543,"marketCap":1566600},{"date":"2024-02-02","current":-0.952146,"twenty":-1.188412,"median":-0.785579,"eighty":-0.621835,"marketCap":4370955},{"date":"2024-02-09","current":-0.749229,"twenty":-1.152886,"median":-0.785861,"eighty":-0.622219,"marketCap":3439440},{"date":"2024-02-16","current":-0.753114,"twenty":-1.13732,"median":-0.786142,"eighty":-0.624733,"marketCap":3457273},{"date":"2024-02-23","current":-0.490741,"twenty":-1.132778,"median":-0.78072,"eighty":-0.622977,"marketCap":2410213},{"date":"2024-03-01","current":-0.579894,"twenty":-1.128236,"median":-0.778114,"eighty":-0.614555,"marketCap":2848078},{"date":"2024-03-08","current":-0.490209,"twenty":-1.123412,"median":-0.776775,"eighty":-0.610637,"marketCap":2407601},{"date":"2024-03-15","current":-0.509136,"twenty":-1.118964,"median":-0.775242,"eighty":-0.592478,"marketCap":2500559},{"date":"2024-03-22","current":-0.525297,"twenty":-1.117335,"median":-0.77346,"eighty":-0.581894,"marketCap":2579931},{"date":"2024-03-28","current":-0.473903,"twenty":-1.113695,"median":-0.765009,"eighty":-0.57889,"marketCap":2327515},{"date":"2024-04-05","current":-0.465895,"twenty":-1.104608,"median":-0.763839,"eighty":-0.572986,"marketCap":2288187},{"date":"2024-04-12","current":-0.451482,"twenty":-1.095124,"median":-0.75721,"eighty":-0.566394,"marketCap":2217396},{"date":"2024-04-19","current":-0.432264,"twenty":-1.089059,"median":-0.754271,"eighty":-0.552942,"marketCap":2123008},{"date":"2024-04-26","current":-0.571741,"twenty":-1.087571,"median":-0.75313,"eighty":-0.548108,"marketCap":2808034},{"date":"2024-05-03","current":-0.472363,"twenty":-1.085339,"median":-0.751778,"eighty":-0.539449,"marketCap":2319949},{"date":"2024-05-10","current":-0.500758,"twenty":-1.085339,"median":-0.75104,"eighty":-0.535412,"marketCap":2459409},{"date":"2024-05-17","current":-0.439161,"twenty":-1.082885,"median":-0.749704,"eighty":-0.531956,"marketCap":2690748},{"date":"2024-05-24","current":-0.433806,"twenty":-1.077523,"median":-0.746816,"eighty":-0.526784,"marketCap":2657934},{"date":"2024-05-31","current":-0.401241,"twenty":-1.074384,"median":-0.745327,"eighty":-0.525355,"marketCap":2458413},{"date":"2024-06-07","current":-0.39656,"twenty":-1.070814,"median":-0.744422,"eighty":-0.519143,"marketCap":2429732},{"date":"2024-06-14","current":-0.401108,"twenty":-1.066065,"median":-0.740166,"eighty":-0.517164,"marketCap":2457594},{"date":"2024-06-21","current":-0.377568,"twenty":-1.064666,"median":-0.739581,"eighty":-0.51564,"marketCap":2313367},{"date":"2024-06-28","current":-0.382383,"twenty":-1.06283,"median":-0.738256,"eighty":-0.512339,"marketCap":2342868},{"date":"2024-07-05","current":-0.388803,"twenty":-1.060328,"median":-0.730984,"eighty":-0.510558,"marketCap":2382202},{"date":"2024-07-12","current":-0.399904,"twenty":-1.055404,"median":-0.728621,"eighty":-0.504943,"marketCap":2450218},{"date":"2024-07-19","current":-0.387867,"twenty":-1.046595,"median":-0.727901,"eighty":-0.50057,"marketCap":2376466},{"date":"2024-07-26","current":-0.433207,"twenty":-1.044662,"median":-0.726722,"eighty":-0.497235,"marketCap":2654267},{"date":"2024-08-02","current":-0.387867,"twenty":-1.044662,"median":-0.723042,"eighty":-0.490722,"marketCap":2376466},{"date":"2024-08-09","current":-0.375428,"twenty":-1.032836,"median":-0.718686,"eighty":-0.487864,"marketCap":2300255},{"date":"2024-08-16","current":-0.323921,"twenty":-1.021158,"median":-0.713275,"eighty":-0.479657,"marketCap":1911305},{"date":"2024-08-23","current":-0.349869,"twenty":-1.017724,"median":-0.712706,"eighty":-0.476893,"marketCap":2064416},{"date":"2024-08-30","current":-0.320347,"twenty":-1.010971,"median":-0.709191,"eighty":-0.473595,"marketCap":1890221},{"date":"2024-09-06","current":-0.280725,"twenty":-1.00874,"median":-0.706471,"eighty":-0.470729,"marketCap":1656426},{"date":"2024-09-13","current":-0.290668,"twenty":-0.991975,"median":-0.702886,"eighty":-0.461724,"marketCap":1715100},{"date":"2024-09-20","current":-0.301169,"twenty":-0.977765,"median":-0.696564,"eighty":-0.452295,"marketCap":1777058},{"date":"2024-09-27","current":-0.299127,"twenty":-0.973418,"median":-0.69255,"eighty":-0.447104,"marketCap":1765010},{"date":"2024-10-04","current":-0.292321,"twenty":-0.97199,"median":-0.684032,"eighty":-0.440437,"marketCap":1724851},{"date":"2024-10-11","current":-0.299808,"twenty":-0.97199,"median":-0.682213,"eighty":-0.435822,"marketCap":1769026},{"date":"2024-10-18","current":-0.30287,"twenty":-0.967975,"median":-0.675644,"eighty":-0.434169,"marketCap":1787098},{"date":"2024-10-25","current":-0.314271,"twenty":-0.963863,"median":-0.674819,"eighty":-0.430608,"marketCap":1854365},{"date":"2024-11-01","current":-0.314951,"twenty":-0.962906,"median":-0.672517,"eighty":-0.421525,"marketCap":1858381},{"date":"2024-11-08","current":-0.324774,"twenty":-0.960181,"median":-0.671876,"eighty":-0.420505,"marketCap":1916341},{"date":"2024-11-15","current":-0.271671,"twenty":-0.954633,"median":-0.671137,"eighty":-0.417158,"marketCap":1703024},{"date":"2024-11-22","current":-0.292466,"twenty":-0.949804,"median":-0.668482,"eighty":-0.412958,"marketCap":1833385},{"date":"2024-11-29","current":-0.299454,"twenty":-0.946568,"median":-0.667598,"eighty":-0.409671,"marketCap":1877186},{"date":"2024-12-06","current":-0.273072,"twenty":-0.942112,"median":-0.661476,"eighty":-0.405628,"marketCap":1711808},{"date":"2024-12-13","current":-0.174833,"twenty":-0.938133,"median":-0.659126,"eighty":-0.401776,"marketCap":1095974},{"date":"2024-12-20","current":-0.207968,"twenty":-0.936184,"median":-0.655759,"eighty":-0.400671,"marketCap":1303688},{"date":"2024-12-27","current":-0.235774,"twenty":-0.935654,"median":-0.655239,"eighty":-0.399904,"marketCap":1478000},{"date":"2025-01-03","current":-0.496858,"twenty":-0.935654,"median":-0.654457,"eighty":-0.39656,"marketCap":3114656},{"date":"2025-01-10","current":-0.295001,"twenty":-0.930536,"median":-0.654348,"eighty":-0.394554,"marketCap":1849272},{"date":"2025-01-17","current":-0.106381,"twenty":-0.928837,"median":-0.651203,"eighty":-0.393264,"marketCap":666873},{"date":"2025-01-24","current":-0.180607,"twenty":-0.927435,"median":-0.643675,"eighty":-0.392161,"marketCap":1132172},{"date":"2025-01-31","current":-1.150592,"twenty":-0.927435,"median":-0.643274,"eighty":-0.390685,"marketCap":7212719},{"date":"2025-02-07","current":-0.868616,"twenty":-0.935654,"median":-0.643675,"eighty":-0.39097,"marketCap":5445095},{"date":"2025-02-14","current":-0.729249,"twenty":-0.931816,"median":-0.654188,"eighty":-0.391379,"marketCap":4571442},{"date":"2025-02-21","current":-0.828102,"twenty":-0.929047,"median":-0.654402,"eighty":-0.391967,"marketCap":5191126},{"date":"2025-02-28","current":-0.542885,"twenty":-0.927867,"median":-0.654295,"eighty":-0.392548,"marketCap":3403184},{"date":"2025-03-07","current":-0.223636,"twenty":-0.930794,"median":-0.654348,"eighty":-0.391967,"marketCap":1401908},{"date":"2025-03-14","current":-1.687172,"twenty":-0.93412,"median":-0.654295,"eighty":-0.390916,"marketCap":10576380},{"date":"2025-03-21","current":-1.639092,"twenty":-0.942112,"median":-0.654457,"eighty":-0.391278,"marketCap":10274981},{"date":"2025-03-28","current":-1.125247,"twenty":-0.961089,"median":-0.655647,"eighty":-0.391967,"marketCap":7053840},{"date":"2025-04-04","current":-1.004552,"twenty":-0.97199,"median":-0.657245,"eighty":-0.392548,"marketCap":6297240},{"date":"2025-04-11","current":-0.693722,"twenty":-0.969313,"median":-0.659283,"eighty":-0.392602,"marketCap":4851150},{"date":"2025-04-17","current":-0.747854,"twenty":-0.96482,"median":-0.661476,"eighty":-0.392827,"marketCap":5229691},{"date":"2025-04-25","current":-0.625433,"twenty":-0.962906,"median":-0.659847,"eighty":-0.393478,"marketCap":4373606},{"date":"2025-05-02","current":-0.584626,"twenty":-0.961998,"median":-0.658732,"eighty":-0.393912,"marketCap":4088244},{"date":"2025-05-09","current":-0.591288,"twenty":-0.95712,"median":-0.655703,"eighty":-0.394554,"marketCap":4134834},{"date":"2025-05-16","current":-0.609485,"twenty":-0.951365,"median":-0.654511,"eighty":-0.394554,"marketCap":4041654},{"date":"2025-05-23","current":-0.612998,"twenty":-0.947406,"median":-0.654348,"eighty":-0.394955,"marketCap":4064949},{"date":"2025-05-30","current":-0.578747,"twenty":-0.944056,"median":-0.652642,"eighty":-0.39656,"marketCap":3837824},{"date":"2025-06-06","current":-0.593176,"twenty":-0.939197,"median":-0.643675,"eighty":-0.397257,"marketCap":3933508},{"date":"2025-06-13","current":-0.650761,"twenty":-0.936537,"median":-0.643554,"eighty":-0.39937,"marketCap":4315369},{"date":"2025-06-20","current":-0.643736,"twenty":-0.935831,"median":-0.643675,"eighty":-0.399797,"marketCap":4268779},{"date":"2025-06-27","current":-0.630562,"twenty":-0.935654,"median":-0.643117,"eighty":-0.399904,"marketCap":4181423},{"date":"2025-07-03","current":-0.654274,"twenty":-0.933352,"median":-0.643432,"eighty":-0.400155,"marketCap":4338663},{"date":"2025-07-11","current":-0.648917,"twenty":-0.930281,"median":-0.643675,"eighty":-0.400357,"marketCap":4303139},{"date":"2025-07-18","current":-0.650761,"twenty":-0.928942,"median":-0.643736,"eighty":-0.400816,"marketCap":4315369},{"date":"2025-07-25","current":-0.643692,"twenty":-0.927435,"median":-0.643714,"eighty":-0.401188,"marketCap":4268488},{"date":"2025-08-01","current":-0.610363,"twenty":-0.92112,"median":-0.643736,"eighty":-0.401241,"marketCap":4047478},{"date":"2025-08-08","current":-0.641979,"twenty":-0.917486,"median":-0.643714,"eighty":-0.401241,"marketCap":4257132},{"date":"2025-08-15","current":-0.629043,"twenty":-0.914118,"median":-0.643675,"eighty":-0.402044,"marketCap":4171348},{"date":"2025-08-22","current":-0.605358,"twenty":-0.90979,"median":-0.643141,"eighty":-0.40318,"marketCap":4233837},{"date":"2025-08-29","current":-0.586206,"twenty":-0.908402,"median":-0.641979,"eighty":-0.403942,"marketCap":4099891},{"date":"2025-09-05","current":-0.607856,"twenty":-0.908402,"median":-0.641101,"eighty":-0.404612,"marketCap":4251308},{"date":"2025-09-12","current":-0.620346,"twenty":-0.905585,"median":-0.639695,"eighty":-0.405628,"marketCap":4338663},{"date":"2025-09-19","current":-0.682797,"twenty":-0.901273,"median":-0.640047,"eighty":-0.406992,"marketCap":4775442},{"date":"2025-09-26","current":-0.668642,"twenty":-0.900862,"median":-0.641132,"eighty":-0.40841,"marketCap":4676439},{"date":"2025-10-03","current":-0.622844,"twenty":-0.89999,"median":-0.640047,"eighty":-0.408945,"marketCap":4356135},{"date":"2025-10-10","current":-0.701949,"twenty":-0.899318,"median":-0.64024,"eighty":-0.409671,"marketCap":4909387},{"date":"2025-10-17","current":-0.724431,"twenty":-0.898596,"median":-0.641163,"eighty":-0.410944,"marketCap":5066627},{"date":"2025-10-24","current":-0.634368,"twenty":-0.89692,"median":-0.641209,"eighty":-0.412155,"marketCap":4436735},{"date":"2025-10-31","current":-0.714397,"twenty":-0.895929,"median":-0.642829,"eighty":-0.412797,"marketCap":4996447},{"date":"2025-11-07","current":-0.694065,"twenty":-0.895779,"median":-0.643141,"eighty":-0.413279,"marketCap":4854246},{"date":"2025-11-14","current":-0.568375,"twenty":-0.893559,"median":-0.643165,"eighty":-0.413992,"marketCap":3975181},{"date":"2025-11-21","current":-0.560234,"twenty":-0.890234,"median":-0.642843,"eighty":-0.415418,"marketCap":4108790},{"date":"2025-11-28","current":-0.57305,"twenty":-0.890217,"median":-0.641617,"eighty":-0.416355,"marketCap":4202782},{"date":"2025-12-05","current":-0.635756,"twenty":-0.890096,"median":-0.641163,"eighty":-0.417987,"marketCap":4662671},{"date":"2025-12-12","current":-0.559319,"twenty":-0.889884,"median":-0.64024,"eighty":-0.418174,"marketCap":4102076},{"date":"2025-12-19","current":-0.580373,"twenty":-0.889315,"median":-0.639057,"eighty":-0.418658,"marketCap":4256492},{"date":"2025-12-26","current":-0.538264,"twenty":-0.887055,"median":-0.638665,"eighty":-0.419306,"marketCap":3947661},{"date":"2026-01-02","current":-0.421091,"twenty":-0.881248,"median":-0.638466,"eighty":-0.419144,"marketCap":3088306},{"date":"2026-01-09","current":-0.747894,"twenty":-0.87971,"median":-0.63734,"eighty":-0.420734,"marketCap":5485101}],"updateTime":1768041092421},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACON\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2601395854","title":"Aclarion Inc trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2601395854","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601395854?lang=en_us&edition=fundamental","pubTime":"2026-01-08 23:00","pubTimestamp":1767884434,"startTime":"0","endTime":"0","summary":"09:59 EST Aclarion (ACON) Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market-moving...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aclarion-inc-trading-halted-volatility-trading-pause-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aclarion-inc-trading-halted-volatility-trading-pause-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ACON","BK4167"],"gpt_icon":0},{"id":"2601622673","title":"Aclarion's AI Back Pain Tech Sees 114% Surge In Demand, Stock Soars","url":"https://stock-news.laohu8.com/highlight/detail?id=2601622673","media":"Benzinga_recent_news","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601622673?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:29","pubTimestamp":1767878940,"startTime":"0","endTime":"0","summary":"Aclarion Inc. (NASDAQ: ACON) provided a corporate update on Thursday, reporting strong commercial momentum.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/08/Muscular-Man-Suffering-From-Back-And-Nec.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/08/Muscular-Man-Suffering-From-Back-And-Nec.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/01/49781264/aclarions-ai-back-pain-tech-sees-114-surge-in-demand-stock-soars","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/01/49781264/aclarions-ai-back-pain-tech-sees-114-surge-in-demand-stock-soars","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4167","ACON"],"gpt_icon":0},{"id":"2601548363","title":"Aclarion Launches CLARITY Trial to Advance Nociscan for Chronic Low Back Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2601548363","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601548363?lang=en_us&edition=fundamental","pubTime":"2026-01-08 19:00","pubTimestamp":1767870048,"startTime":"0","endTime":"0","summary":"Aclarion Inc. has announced the launch of the CLARITY trial in 2025, with seven activated sites. The company aims to enroll approximately 25% of patients in the trial by the end of the second quarter of 2026, with the first internal readout on interim data anticipated in the third quarter of 2026. The CLARITY trial is part of Aclarion’s strategy to advance clinical validation for its Nociscan platform, a cloud-based solution utilizing MR spectroscopy and augmented intelligence to identify the location of chronic low back pain. Results from this trial have not yet been presented; interim data is expected in 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aclarion Inc. published the original content used to generate this news brief ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL5gwfj1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00B3QW5Z07.USD","LU2210150020.SGD","BK4112","LU2095319765.USD","NDAQ","SG9999014005.SGD","ACON","IE00BKPKM429.USD","SG9999014039.USD","SG9999014013.SGD","BK4588","SG9999014021.USD","LU2210149790.SGD","IE00B64PRP62.GBP","BK4585","BK4167","LU0314104364.USD"],"gpt_icon":0},{"id":"2601635553","title":"Aclarion Inc - Aims to Enroll 25% in Clarity Trial by Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2601635553","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601635553?lang=en_us&edition=fundamental","pubTime":"2026-01-08 19:00","pubTimestamp":1767870001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA5QWL3R:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACON","BK4167","ACONW"],"gpt_icon":0},{"id":"2601363849","title":"Aclarion Provides 2025 Update and 2026 Corporate Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2601363849","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601363849?lang=en_us&edition=fundamental","pubTime":"2026-01-08 19:00","pubTimestamp":1767870001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA5QWL3R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","ACON","ACONW"],"gpt_icon":0},{"id":"2601363574","title":"Aclarion Inc - Cash Resources Sufficient to Fund Operations Into 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2601363574","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601363574?lang=en_us&edition=fundamental","pubTime":"2026-01-08 19:00","pubTimestamp":1767870001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA5QWL3R:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACON","BK4167","ACONW"],"gpt_icon":0},{"id":"2601891509","title":"BRIEF-Aclarion Announces First Patient Enrollments At Two Additional Clarity Trial Sites","url":"https://stock-news.laohu8.com/highlight/detail?id=2601891509","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601891509?lang=en_us&edition=fundamental","pubTime":"2026-01-06 19:40","pubTimestamp":1767699649,"startTime":"0","endTime":"0","summary":"BRIEF-Aclarion Announces First Patient Enrollments At Two Additional Clarity Trial Sites Jan 6 (Reuters) - Aclarion Inc ACON.O:ACLARION ANNOUNCES FIRST PATIENT ENROLLMENTS AT TWO ADDITIONAL CLARITY TR","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nFWN3Y61A2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","ACONW","ACON"],"gpt_icon":0},{"id":"2601998088","title":"Aclarion Inc - First Interim Data Readout Expected in 3Q 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2601998088","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601998088?lang=en_us&edition=fundamental","pubTime":"2026-01-06 19:01","pubTimestamp":1767697292,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nFWN3Y61A2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","ACONW","ACON"],"gpt_icon":0},{"id":"2601993338","title":"Aclarion Inc - Acclarion Targets Full Enrollmentof 300 Patients by Mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2601993338","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601993338?lang=en_us&edition=fundamental","pubTime":"2026-01-06 19:01","pubTimestamp":1767697292,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nFWN3Y61A2:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACON","BK4167","ACONW"],"gpt_icon":0},{"id":"2601807899","title":"Aclarion Announces First Patient Enrollments at Two Additional Clarity Trial Sites and Provides Guidance on Expected Availability of Initial Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2601807899","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601807899?lang=en_us&edition=fundamental","pubTime":"2026-01-06 19:01","pubTimestamp":1767697292,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nFWN3Y61A2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","ACON"],"gpt_icon":0},{"id":"2601899352","title":"Aclarion Launches CLARITY Trial with First Patients Enrolled at Leading Spine Centers","url":"https://stock-news.laohu8.com/highlight/detail?id=2601899352","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601899352?lang=en_us&edition=fundamental","pubTime":"2026-01-06 19:00","pubTimestamp":1767697252,"startTime":"0","endTime":"0","summary":"Aclarion Inc. has announced the enrollment of the first patients at Northwestern Medicine and Scripps Health for its pivotal CLARITY trial, which is designed to evaluate the company's technology for identifying the source of chronic low back pain. Seven leading U.S. spine centers are now participating in the study. The company aims to enroll approximately 25% of patients by the end of the second quarter of 2026, with an initial interim data readout expected after the first cohort completes a three-month follow-up visit in the third quarter of 2026. Results from the trial have not yet been presented; additional patient data will be incorporated on a rolling basis until enrollment is complete or until statistically significant results are observed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDL3mB8gj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","SG9999014039.USD","IE00B64PRP62.GBP","SG9999014013.SGD","IE00B3QW5Z07.USD","BK4167","BK4588","NDAQ","IE00BKPKM429.USD","BK4585","SG9999014005.SGD","LU2210149790.SGD","BK4112","LU2095319765.USD","IE00BGHQF748.EUR","ACON","SG9999014021.USD","LU0314104364.USD"],"gpt_icon":0},{"id":"2588888882","title":"Aclarion Nociscan Study Published in Leading Spine Surgery Journal","url":"https://stock-news.laohu8.com/highlight/detail?id=2588888882","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588888882?lang=en_us&edition=fundamental","pubTime":"2025-12-04 21:11","pubTimestamp":1764853914,"startTime":"0","endTime":"0","summary":"Aclarion Inc. has announced the publication of a featured article on its Nociscan technology in the Special Pain Issue of the International Journal of Spine Surgery . The article highlights a successful clinical case in which Nociscan, a noninvasive SaaS platform, was used alongside traditional MRI to more accurately identify the source of chronic low back pain in a patient. As a result, the surgeon was able to limit surgical intervention to the affected disc, leading to the elimination of the patient's pain and a full return to an active lifestyle. These results, which strengthen the clinical evidence supporting Nociscan, have already been published in advance online by the IJSS.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aclarion","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nNDL4p81Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACON","BK4167"],"gpt_icon":0},{"id":"2588505348","title":"Press Release: Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2588505348","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588505348?lang=en_us&edition=fundamental","pubTime":"2025-12-02 21:00","pubTimestamp":1764680400,"startTime":"0","endTime":"0","summary":"-- Proven commercial leader with 20+ years of experience driving revenue. growth and market adoption for early-stage and high-growth MedTech. Jason is a proven commercial leader with more than 20 years of experience accelerating revenue growth and building high-performing teams for high-growth MedTech companies, including roles at Relievant Medsystems , Kyphon , and Intrinsic Therapeutics. His background in successfully launching breakthrough technologies and establishing new market categories across spine, orthopedics, and pain management makes him exceptionally well-positioned to drive the adoption of Nociscan in the Eastern U.S.\"Jason's hire represents another significant commercial milestone for the Company,\" said Brent Ness, CEO of Aclarion. \"The growing demand for Nociscan through real-world evidence trials, and the national CLARITY randomized controlled trial, necessitates additional commercial resources in the densely populated Eastern U.S. Jason brings the critical early-stage","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4161","EML","ACON","BK4167"],"gpt_icon":0},{"id":"2588570518","title":"Aclarion CEO Brent Ness Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2588570518","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588570518?lang=en_us&edition=fundamental","pubTime":"2025-12-02 06:00","pubTimestamp":1764626430,"startTime":"0","endTime":"0","summary":"Brent Ness, Chief Executive Officer and Director of Aclarion Inc., reported the acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aclarion Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 01, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDL6RbYM3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Aclarion CEO Brent Ness Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","ACON"],"gpt_icon":0},{"id":"2584154138","title":"Aclarion Is Maintained at Buy by Ascendiant Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2584154138","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584154138?lang=en_us&edition=fundamental","pubTime":"2025-11-20 18:51","pubTimestamp":1763635860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ACON/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 20, 2025 05:51 ET (10:51 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACON","BK4167"],"gpt_icon":0},{"id":"2582374728","title":"Aclarion Q3 EPS $(2.93) Misses $(2.62) Estimate, Sales $18.942K Miss $40.000K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2582374728","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582374728?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:52","pubTimestamp":1762955533,"startTime":"0","endTime":"0","summary":"Aclarion (NASDAQ:ACON) reported quarterly losses of $(2.93) per share which missed the analyst consensus estimate of $(2.62) by 11.83 percent. This is a 99.8 percent increase over losses of $(1.50 thousand) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48801864/aclarion-q3-eps-2-93-misses-2-62-estimate-sales-18-942k-miss-40-000k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","ACON"],"gpt_icon":0},{"id":"2581238437","title":"Press Release: Aclarion Appoints Dan Isherwood as UK Commercial Director to Drive Adoption and Market Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2581238437","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581238437?lang=en_us&edition=fundamental","pubTime":"2025-11-05 19:00","pubTimestamp":1762340400,"startTime":"0","endTime":"0","summary":"-- Marks Aclarion's first commercial sales hire with seasoned HealthTech. leader and proven track record of advancing musculoskeletal imaging and. -- Experiencing strong commercial traction in UK as first market worldwide. \"Dan's hire represents a significant commercial milestone for the Company,\" said Brent Ness, CEO of Aclarion. \"The UK represents the first market where physicians can order Nociscan for their patients without navigating the friction around who is going to pay for the scan. With this barrier gone for over 5 million patients in the UK, combined with our partnership with The London Clinic, and now the addition of Dan as the Company's first dedicated hire focused on driving scan volume, we are excited to see how this builds on the strong early growth we are already seeing in the UK market.\". Dan joins Aclarion following an accomplished career that spans key roles in advanced imaging and spine technology at industry leaders, including J&J MedTech , EOS Imaging , and NuVas","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACON","BK4167"],"gpt_icon":0},{"id":"2575532299","title":"BRIEF-Aclarion Inc - Clarity Trial On Schedule, Early Readouts Expected Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2575532299","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575532299?lang=en_us&edition=fundamental","pubTime":"2025-10-14 18:34","pubTimestamp":1760438073,"startTime":"0","endTime":"0","summary":"BRIEF-Aclarion Inc - Clarity Trial On Schedule, Early Readouts Expected Q2 2026Oct 14 (Reuters) - Aclarion Inc ACON.O:ACLARION INC - CLARITY TRIAL ON SCHEDULE, EARLY READOUTS EXPECTED Q2 2026Source text: ID:nGNX4cJbhjFurther company coverage: ACON.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nFWN3VV1EL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACON","BK4167"],"gpt_icon":0},{"id":"2575951142","title":"Aclarion Inc. Announces $2.5 Million Registered Direct Offering of 64,000 Shares and Pre-Funded Warrants for 236,000 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2575951142","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575951142?lang=en_us&edition=fundamental","pubTime":"2025-10-14 18:06","pubTimestamp":1760436384,"startTime":"0","endTime":"0","summary":"Aclarion Inc. has entered into a Securities Purchase Agreement with unnamed purchasers to sell a total of 64,000 shares of common stock at $8.36 per share and pre-funded warrants to purchase up to 236,000 shares of common stock. The transactions are expected to generate approximately $2.5 million in gross proceeds before fees and expenses. Dawson James Securities, Inc. is acting as the exclusive placement agent for the offering.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aclarion Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 14, 2025, and is solely responsible for the i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nNDL3N7RDD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACON","BK4167"],"gpt_icon":0},{"id":"2574589121","title":"Aclarion Inc to Present at LD Micro Main Event XIX","url":"https://stock-news.laohu8.com/highlight/detail?id=2574589121","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574589121?lang=en_us&edition=fundamental","pubTime":"2025-10-09 18:01","pubTimestamp":1760004063,"startTime":"0","endTime":"0","summary":"Aclarion Inc., a healthcare technology company specializing in biomarkers and AI algorithms to help physicians identify the location of chronic low back pain, will present at the LD Micro Main Event XIX on Monday, October 20, 2025, at 12:00 PM PT in San Diego, California. Executive Chairman Jeff Thramann and CEO Brent Ness will lead the presentation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aclarion Inc. published the original content used to generate this news brief via Newsfile  on October 09, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251009:nNDLvT6Lg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACON","BK4167"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":29,"code":"91000000","status":"200"}]}}